Alto Neuroscience
Los Altos
About Alto Neuroscience
Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through its AI-enabled biomarker platform, Alto Neuroscience combines rich sources of information on patients’ brain activity and behavior to rapidly develop highly-effective medicines for targeted populations. Alto Neuroscience aims to replace today's trial-and-error clinical approach by aligning the right Alto drug with the right patient, redefining psychiatry at a time when the world needs it most.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $421.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2026)
- Ticker: nyse:ANRO
- Website: altoneuroscience.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biopharma, Biotechnology, Neuroscience, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/alto-neuroscience-80314 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.